المؤلفون: Saito K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Isayama H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan. isayama-tky@umin.ac.jp.; Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan. isayama-tky@umin.ac.jp., Sakamoto Y; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Ishigaki K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Tanaka M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Watadani T; Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Arita J; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Takahara N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Mizuno S; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Kogure H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Ijichi H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Tateishi K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Tada M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Hasegawa K; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Fukayama M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Kokudo N; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan.

المصدر: Medical oncology (Northwood, London, England) [Med Oncol] 2018 May 30; Vol. 35 (7), pp. 100. Date of Electronic Publication: 2018 May 30.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/adverse effects, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Deoxycytidine/*analogs & derivatives , Leucovorin/*administration & dosage , Oxonic Acid/*administration & dosage , Pancreatic Neoplasms/*drug therapy , Tegafur/*administration & dosage, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Drug Combinations ; Female ; Humans ; Leucovorin/adverse effects ; Male ; Middle Aged ; Oxonic Acid/adverse effects ; Pancreatic Neoplasms/pathology ; Recurrence ; Survival Analysis ; Tegafur/adverse effects ; Treatment Outcome ; Gemcitabine

المؤلفون: Takahara N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Isayama H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. isayama-tky@umin.ac.jp., Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Sasaki T; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Ishigaki K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Saito K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Akiyama D; Department of Gastroenterology, JR Tokyo General Hospital, Tokyo, Japan., Uchino R; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Mizuno S; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Yagioka H; Department of Gastroenterology, Tokyo Metropolitan Police Hospital, Tokyo, Japan., Kogure H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Togawa O; Department of Gastroenterology, Kanto Central Hospital, Tokyo, Japan., Matsubara S; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Ito Y; Department of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan., Toda N; Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan., Tada M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

المصدر: Investigational new drugs [Invest New Drugs] 2017 Jun; Vol. 35 (3), pp. 269-276. Date of Electronic Publication: 2017 Jan 26.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biliary Tract Neoplasms/*drug therapy , Cisplatin/*therapeutic use , Deoxycytidine/*analogs & derivatives , Oxonic Acid/*therapeutic use , Tegafur/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/adverse effects ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Oxonic Acid/adverse effects ; Retrospective Studies ; Tegafur/adverse effects ; Young Adult ; Gemcitabine

المؤلفون: Takahara N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Isayama H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. isayama-tky@umin.ac.jp., Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Ishigami H; Department of Chemotherapy, The University of Tokyo, Tokyo, Japan., Satoi S; Department of Surgery, Kansai Medical University, Osaka, Japan., Mizuno S; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Kogure H; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Matsubara S; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Yamamoto N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Yamaguchi H; Department of Surgery, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan., Tada M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Kitayama J; Department of Surgery, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan., Watanabe T; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan., Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

المصدر: Investigational new drugs [Invest New Drugs] 2016 Oct; Vol. 34 (5), pp. 636-42. Date of Electronic Publication: 2016 Jun 23.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Oxonic Acid*/administration & dosage , Oxonic Acid*/adverse effects , Oxonic Acid*/therapeutic use , Paclitaxel*/administration & dosage , Paclitaxel*/adverse effects , Paclitaxel*/therapeutic use , Tegafur*/administration & dosage , Tegafur*/adverse effects , Tegafur*/therapeutic use, Adenocarcinoma/*drug therapy , Ascites/*drug therapy , Pancreatic Neoplasms/*drug therapy, Administration, Intravenous ; Adult ; Aged ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Antimetabolites, Antineoplastic/therapeutic use ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/adverse effects ; Antineoplastic Agents, Phytogenic/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Drug Combinations ; Drug Resistance, Neoplasm ; Female ; Humans ; Infusions, Parenteral ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Treatment Outcome ; Gemcitabine

المؤلفون: Takahara N; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan., Isayama H, Nakai Y, Sasaki T, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2013 Nov; Vol. 72 (5), pp. 985-90. Date of Electronic Publication: 2013 Sep 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Salvage Therapy*/adverse effects, Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Organoplatinum Compounds/*therapeutic use , Oxonic Acid/*therapeutic use , Pancreatic Neoplasms/*drug therapy , Tegafur/*therapeutic use, Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Combinations ; Female ; Follow-Up Studies ; Humans ; Incidence ; Liver Neoplasms/secondary ; Lymphatic Metastasis ; Male ; Middle Aged ; Neutropenia/chemically induced ; Neutropenia/epidemiology ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Retrospective Studies ; Survival Analysis ; Tegafur/administration & dosage ; Tegafur/adverse effects ; Tokyo/epidemiology

المؤلفون: Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Japan., Isayama H, Sasaki T, Sasahira N, Tsujino T, Toda N, Kogure H, Matsubara S, Ito Y, Togawa O, Arizumi T, Hirano K, Tada M, Omata M, Koike K

المصدر: British journal of cancer [Br J Cancer] 2012 Jun 05; Vol. 106 (12), pp. 1934-9. Date of Electronic Publication: 2012 May 03.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Deoxycytidine/*analogs & derivatives , Oxonic Acid/*administration & dosage , Pancreatic Neoplasms/*drug therapy , Tegafur/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Deoxycytidine/administration & dosage ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Gemcitabine

المؤلفون: Sasaki T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Isayama H, Nakai Y, Mizuno S, Yamamoto K, Yagioka H, Yashima Y, Kawakubo K, Kogure H, Togawa O, Matsubara S, Ito Y, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Omata M, Koike K

المصدر: Investigational new drugs [Invest New Drugs] 2012 Apr; Vol. 30 (2), pp. 708-13. Date of Electronic Publication: 2010 Oct 06.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*, Antimetabolites, Antineoplastic/*therapeutic use , Biliary Tract Neoplasms/*drug therapy , Deoxycytidine/*analogs & derivatives , Oxonic Acid/*therapeutic use , Tegafur/*therapeutic use, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Biliary Tract Neoplasms/diagnostic imaging ; Biliary Tract Neoplasms/mortality ; Biliary Tract Neoplasms/pathology ; Deoxycytidine/therapeutic use ; Disease Progression ; Drug Administration Schedule ; Drug Combinations ; Female ; Humans ; Japan ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Tegafur/administration & dosage ; Tegafur/adverse effects ; Time Factors ; Tomography, X-Ray Computed ; Treatment Failure ; Gemcitabine

المؤلفون: Nakai Y; Department of Gastroenterology, University of Tokyo, Bunkyo-ku, Tokyo, Japan., Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Tateishi K, Toda N, Tada M, Omata M, Koike K

المصدر: Pancreas [Pancreas] 2010 Oct; Vol. 39 (7), pp. 989-93.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8608542 Publication Model: Print Cited Medium: Internet ISSN: 1536-4828 (Electronic) Linking ISSN: 08853177 NLM ISO Abbreviation: Pancreas Subsets: MEDLINE

مواضيع طبية MeSH: Antimetabolites, Antineoplastic/*therapeutic use , Oxonic Acid/*therapeutic use , Pancreatic Neoplasms/*drug therapy , Tegafur/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms/mortality ; Prognosis ; Gemcitabine

المؤلفون: Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan., Isayama H, Sasaki T, Sasahira N, Kogure H, Hirano K, Tsujino T, Ijichi H, Tateishi K, Tada M, Omata M, Koike K

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2010 Aug; Vol. 40 (8), pp. 774-80. Date of Electronic Publication: 2010 May 12.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*, Antimetabolites, Antineoplastic/*therapeutic use , Deoxycytidine/*analogs & derivatives , Oxonic Acid/*therapeutic use , Pancreatic Neoplasms/*drug therapy , Tegafur/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Deoxycytidine/pharmacology ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Pancreatic Neoplasms/mortality ; Peritoneal Neoplasms/secondary ; Prognosis ; Retrospective Studies ; Survival Rate ; Gemcitabine

المؤلفون: Sasaki T; Department of Gastroenterology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. sasakit-tky@umin.ac.jp, Isayama H, Yashima Y, Yagioka H, Kogure H, Arizumi T, Togawa O, Matsubara S, Ito Y, Nakai Y, Sasahira N, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M

المصدر: Oncology [Oncology] 2009; Vol. 77 (1), pp. 71-4. Date of Electronic Publication: 2009 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antimetabolites, Antineoplastic/*therapeutic use , Biliary Tract Neoplasms/*drug therapy , Neoplasm Recurrence, Local/*drug therapy , Oxonic Acid/*therapeutic use , Tegafur/*therapeutic use, Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Biliary Tract Neoplasms/pathology ; Disease Progression ; Drug Combinations ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Staging ; Prognosis ; Prospective Studies ; Survival Rate ; Treatment Outcome